Literature DB >> 17574095

Amyotrophic lateral sclerosis.

J D Mitchell1, G D Borasio2.   

Abstract

Amyotrophic lateral sclerosis (known in the UK as motor neuron disease) is a devastating illness with uncertain pathogenesis. In this Seminar, we review its natural history, clinical features, diagnostic criteria, variant and mimic syndromes, genetic forms, and epidemiology. Several hypotheses about causes of the disorder are discussed, such as excitotoxicity and oxidant stress, and we review past and present putative disease-modifying treatments. Disease-management strategies, from telling the patient about their illness to end-of-life decisions and palliative care, are presented. We review options for control of the main symptoms of amyotrophic lateral sclerosis--including dysphagia, dysarthria, respiratory distress, pain, and psychological disorders--and care in the terminal phase. The need for good psychosocial and spiritual care of patients and families is emphasised. We conclude with an overview of some current major issues and future prospects, ranging from the search for disease markers to challenging developments such as stem-cell and gene therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17574095     DOI: 10.1016/S0140-6736(07)60944-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  172 in total

Review 1.  Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis etiology and survival.

Authors:  John D Beard; Freya Kamel
Journal:  Epidemiol Rev       Date:  2014-10-31       Impact factor: 6.222

2.  Wild type TDP-43 induces neuro-inflammation and alters APP metabolism in lentiviral gene transfer models.

Authors:  Alexander M Herman; Preeti J Khandelwal; G William Rebeck; Charbel E-H Moussa
Journal:  Exp Neurol       Date:  2012-02-28       Impact factor: 5.330

3.  De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosis.

Authors:  Mariely DeJesus-Hernandez; Jannet Kocerha; NiCole Finch; Richard Crook; Matt Baker; Pamela Desaro; Amelia Johnston; Nicola Rutherford; Aleksandra Wojtas; Kathleen Kennelly; Zbigniew K Wszolek; Neill Graff-Radford; Kevin Boylan; Rosa Rademakers
Journal:  Hum Mutat       Date:  2010-05       Impact factor: 4.878

4.  Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics.

Authors:  Henrik Ryberg; Jiyan An; Samuel Darko; Jonathan Llyle Lustgarten; Matt Jaffa; Vanathi Gopalakrishnan; David Lacomis; Merit Cudkowicz; Robert Bowser
Journal:  Muscle Nerve       Date:  2010-07       Impact factor: 3.217

5.  [Oncology and palliative medicine].

Authors:  J Gärtner; J Wolf; R Voltz; M Hallek
Journal:  Internist (Berl)       Date:  2011-01       Impact factor: 0.743

6.  Targeted axonal import (TAxI) peptide delivers functional proteins into spinal cord motor neurons after peripheral administration.

Authors:  Drew L Sellers; Jamie M Bergen; Russell N Johnson; Heidi Back; John M Ravits; Philip J Horner; Suzie H Pun
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-17       Impact factor: 11.205

7.  Cardiovascular disease and diagnosis of amyotrophic lateral sclerosis: A population based study.

Authors:  Marianthi-Anna Kioumourtzoglou; Ryan M Seals; Ole Gredal; Murray A Mittleman; Johnni Hansen; Marc G Weisskopf
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2016-07-20       Impact factor: 4.092

8.  Conjugal amyotrophic lateral sclerosis.

Authors:  John D Dewitt; Julia Kwon; Rebecca Burton; Jeffrey S Stroup
Journal:  Proc (Bayl Univ Med Cent)       Date:  2012-01

9.  Immunological aspects in amyotrophic lateral sclerosis.

Authors:  Maria Carolina O Rodrigues; Júlio C Voltarelli; Paul R Sanberg; Cesario V Borlongan; Svitlana Garbuzova-Davis
Journal:  Transl Stroke Res       Date:  2012-05-03       Impact factor: 6.829

10.  Meditation training for people with amyotrophic lateral sclerosis and their caregivers.

Authors:  Francesco Pagnini; Chiara Di Credico; Ramona Gatto; Viviana Fabiani; Gabriella Rossi; Christian Lunetta; Anna Marconi; Federica Fossati; Gianluca Castelnuovo; Aurora Tagliaferri; Paolo Banfi; Massimo Corbo; Valeria Sansone; Enrico Molinari; Gherardo Amadei
Journal:  J Altern Complement Med       Date:  2013-12-11       Impact factor: 2.579

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.